GATA-3 and the regulation of the mammary luminal cell fate - Wikidata - wikimedia - TriplyDB

GATA-3 and the regulation of the mammary luminal cell fate

GATA-3 and the regulation of the mammary luminal cell fate

http://www.wikidata.org/entity/Q24648936

about

Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours JARID1B is a luminal lineage-driving oncogene in breast cancer GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transition Coordinate regulation of GATA-3 and Th2 cytokine gene expression by the RNA-binding protein HuR GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis New and emerging factors in tumorigenesis: an overview Cooperating transcription factors mediate the function of estrogen receptor RANKL/RANK-beyond bones Gain- and Loss-of-Function Mutations in the Breast Cancer Gene GATA3 Result in Differential Drug Sensitivity Identification of functionally related genes using data mining and data integration: a breast cancer case study.Indole-3-carbinol triggers aryl hydrocarbon receptor-dependent estrogen receptor (ER)alpha protein degradation in breast cancer cells disrupting an ERalpha-GATA3 transcriptional cross-regulatory loop.Unraveling the regulatory connections between two controllers of breast cancer cell fate GATA3 and TRPS1 are distinct biomarkers and prognostic factors in breast cancer: database mining for GATA family members in malignancies Regulatory network of GATA3 in pediatric acute lymphoblastic leukemia Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with ERalpha.Family-specific, novel, deleterious germline variants provide a rich resource to identify genetic predispositions for BRCAx familial breast cancer.Nuclear CSPP1 expression defined subtypes of basal-like breast cancer.RARRES3 suppresses breast cancer lung metastasis by regulating adhesion and differentiation Adiponectin deficiency limits tumor vascularization in the MMTV-PyV-mT mouse model of mammary cancer.Estrogen receptor coregulators and pioneer factors: the orchestrators of mammary gland cell fate and development.Absent, small or homeotic 2-like protein (ASH2L) enhances the transcription of the estrogen receptor α gene through GATA-binding protein 3 (GATA3).KAT6A, a chromatin modifier from the 8p11-p12 amplicon is a candidate oncogene in luminal breast cancer BZL101, a phytochemical extract from the Scutellaria barbata plant, disrupts proliferation of human breast and prostate cancer cells through distinct mechanisms dependent on the cancer cell phenotype.GATA3 cooperates with PARP1 to regulate CCND1 transcription through modulating histone H1 incorporation.The role of miR-206 in the epidermal growth factor (EGF) induced repression of estrogen receptor-alpha (ERalpha) signaling and a luminal phenotype in MCF-7 breast cancer cells.Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.Breast cancer expression of YKL-40 correlates with tumour grade, poor differentiation, and other cancer markers.Inferring regulatory element landscapes and transcription factor networks from cancer methylomes.Estrogen-induced aurora kinase-A (AURKA) gene expression is activated by GATA-3 in estrogen receptor-positive breast cancer cells.Cell polarity, epithelial-mesenchymal transition, and cell-fate decision gene expression in ductal carcinoma in situ.Genomic antagonism between retinoic acid and estrogen signaling in breast cancer.GATA3 Expression Is a Poor Prognostic Factor in Soft Tissue Sarcomas Reprogramming non-mammary and cancer cells in the developing mouse mammary gland Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung.Prognostic and clinicopathological value of GATA binding protein 3 in breast cancer: A systematic review and meta-analysis.Cell type-specific binding patterns reveal that TCF7L2 can be tethered to the genome by association with GATA3.Reprogramming cell fates in the mammary microenvironment.MiR-573 inhibits prostate cancer metastasis by regulating epithelial-mesenchymal transition S100A8/A9 is associated with estrogen receptor loss in breast cancer.

P2860

Q21030553-9B85605D-DA45-4B1E-9FEB-532591E731A6 Q24299326-69D1278A-7D14-45BF-A1EF-775573E1CFD6 Q24301339-86DCD39C-A04B-4186-A06A-B825250D4DE3 Q24304394-45BC948E-6142-4D09-920E-1D3D894CBEB4 Q24315703-86637436-D1C6-4FC1-8E32-7D2E15B66EF4 Q26801253-DCBFED06-9EBB-419C-91EC-3C4A322CA6C4 Q26996464-33FAE22C-E108-49BB-A490-0933E401AFEA Q28308042-266EDD9D-5A22-4E26-AA15-E214A3BA8B68 Q28553888-7BFD2F5D-7EA0-42B4-85CB-8DA282FDED29 Q33510484-86EF540E-8943-48A6-9A5D-4B08841748D1 Q33761468-34A6E014-7BE8-42D0-86B5-368B4A0586D2 Q33791223-C20E3075-5C99-47A2-8F49-9B2BF1EB4D96 Q33798578-D7E6E3B8-1180-4718-B3EC-76804A196420 Q33829399-7A875777-FEC7-4A6E-AF73-95236C3269C9 Q33848844-BA478065-25C6-499B-B378-6EF0F8ECB388 Q33850753-8841C3C4-C6F3-4529-A8A3-6787CEBBB888 Q33918128-7630D918-5C8E-435E-8F20-DFFD5FE3A0CF Q33991449-367AD1E4-ED4B-4A0C-83F8-3B2ABE8D0D4A Q34001014-1FCF3F99-9DE1-49AA-9677-6B722631356E Q34391427-BEFE69E5-59C7-4999-BE9E-B824697EB714 Q34467617-D439CB7F-2B5F-425E-9C15-5E357FB0370C Q34528297-3406E3E7-2CB0-4BC6-8669-FE1C7A2C8129 Q34581850-B46AA9D4-5137-4790-8F43-2AB0BA421BAF Q34817460-31CDCC3F-10CF-48C2-9ECD-2F63EA9948A0 Q34979726-CD96CC77-1B02-4A98-A4CE-30357086B143 Q35000657-D7037A05-CE07-4541-864F-6D9C59A93CC2 Q35029548-A8740E62-C4AF-425F-AF91-3A3DB0FA53C8 Q35527112-DEEFEA5D-D163-4F35-820D-BEB8DB298603 Q35702332-F681D38B-4289-44C7-BC74-2391B61147D6 Q35850229-4504123A-CBA2-4F8B-B3F0-4A1EFEA6C1E6 Q35909091-07A73C68-7BBE-4D15-B9D1-7F3238367F34 Q36028691-8360FC19-41B8-49E2-BB95-D66F8ACAA9A4 Q36036337-AF7F7368-EDA3-4F3A-8860-FF02CD88FB60 Q36052112-041C6616-888A-4873-A595-ED153AB1E95E Q36240960-BF90CC30-25A7-4B31-B4C5-30F6528787C3 Q36342134-6E2369E0-6326-4443-862D-6DEC201B776A Q36378040-5DCBD3A3-62C0-45D2-AE80-B18AD10B7FDE Q36382636-EF2DF7F1-BF18-4204-B702-6CC9AF3968D4 Q36546530-52CF416D-19F6-411B-93C5-A00D40C051D1 Q36640358-93D85267-78EC-4CB0-AF6D-173321AD7641

P2860

GATA-3 and the regulation of the mammary luminal cell fate

http://www.wikidata.org/entity/Q24648936

description

2008 nî lūn-bûn

@nan

2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

GATA-3 and the regulation of the mammary luminal cell fate

@ast

GATA-3 and the regulation of the mammary luminal cell fate

@en

GATA-3 and the regulation of the mammary luminal cell fate

@nl

type

label

GATA-3 and the regulation of the mammary luminal cell fate

@ast

GATA-3 and the regulation of the mammary luminal cell fate

@en

GATA-3 and the regulation of the mammary luminal cell fate

@nl

prefLabel

GATA-3 and the regulation of the mammary luminal cell fate

@ast

GATA-3 and the regulation of the mammary luminal cell fate

@en

GATA-3 and the regulation of the mammary luminal cell fate

@nl

P1433

Q24648936-74285D7C-144E-43C6-8214-1467CA0DF9DB

P1476

Q24648936-F39FA650-CA11-4D45-8AF4-645A472D7BF6

P2093

Q24648936-48DCCC3F-2701-4EFC-8E23-C1784405492F

Q24648936-4A39BD3D-45F6-410C-B5E1-583A3B40A415

P2860

Q24648936-087BEAA2-B0E9-496A-918B-7726F61079E4

Q24648936-08C12E70-446B-49FC-827B-D643052089E2

Q24648936-14F70F0A-71FD-4D17-B5C4-EA48B505EA65

Q24648936-192DD464-1316-4980-84E0-DD7F7323FC78

Q24648936-19CC315A-6243-439E-B814-5B44AE4803AB

Q24648936-1B3A733C-8E8F-4925-8D16-AAC825F125D9

Q24648936-1C88331D-10DC-4A7C-B93F-DF1CAE78068E

Q24648936-1D469C50-8637-4BFA-9CCD-056EEED7042F

Q24648936-2284FF90-1EDE-49A5-904D-1DACF5C01D80

Q24648936-23CD810D-1F34-4893-8185-737A2F115844

P304

Q24648936-19150604-85CA-45FC-A502-0D8085F25D83

P31

Q24648936-BB0F269B-7665-49DF-9393-A18D8689A818

P3181

Q24648936-693E0862-A69E-4772-B52F-9ABB6C6EEA89

P356

Q24648936-3956E86F-74FF-472F-A5C0-E7D8FD259E0B

P407

Q24648936-8BC163D1-B385-40A5-8EB5-A7330DBAC5A1

P433

Q24648936-56C93BEC-2291-41B4-A9C9-DF799590A475

P478

Q24648936-830A4B52-A816-4842-9849-8E44833CA90E

P50

Q24648936-110E2EBE-7DCD-40F1-9210-AC4814BAC1BB

Q24648936-D89CEBB5-8D6E-44A8-9102-A402C82CC15E

P577

Q24648936-567762CC-AB6D-4332-A9E1-D844BCE1E4B3

P5875

Q24648936-616FBAD0-6618-41BB-9D31-89BFD8BDB1D0

P698

Q24648936-149BBF75-405C-4661-8B26-0FE4A8CDFDE0

P921

Q24648936-01EAA9BB-8D0E-4B68-B30F-E86EF7D1B34E

P932

Q24648936-20651B02-237A-474B-AFD8-379D91B8EB94

P3181

P356

J.CEB.2008.02.003

P1433

Current Opinion in Cell Biology

P1476

GATA-3 and the regulation of the mammary luminal cell fate

@en

P2093

Hosein Kouros-Mehr

http://www.w3.org/2001/XMLSchema#string

Seth K Bechis

http://www.w3.org/2001/XMLSchema#string

P2860

From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response

The GATA2 transcription factor negatively regulates the proliferation of neuronal progenitors

Candidate regulators of mammary branching morphogenesis identified by genome-wide transcript analysis

GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland

GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Gene expression profiling predicts clinical outcome of breast cancer

A bivalent chromatin structure marks key developmental genes in embryonic stem cells

Molecular portraits of human breast tumours

Repeated observation of breast tumor subtypes in independent gene expression data sets

P304

164-70

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1112317

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.CEB.2008.02.003

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5493104

http://www.w3.org/2001/XMLSchema#string

P698

18358709

http://www.w3.org/2001/XMLSchema#string

P921

P932

2397451

http://www.w3.org/2001/XMLSchema#string